3 hours Biogen (NASDAQ:BIIB) PT Lowered to $230.00MarketBeat
BMO Capital Markets dropped their price target on shares of Biogen from $260.00 to $230.00 and set an “outperform” rating on the stock in a research note on Thursday.
Biogen (BIIB) · Markets · Nasdaq 100 · Science
X